Skip to main content
Log in

Adenosine triphosphatase in nerves and ganglia of rats with streptozotocin-induced diabetes or galactosaemia; effects of aldose reductase inhibition

  • Originals
  • Published:
Diabetologia Aims and scope Submit manuscript

Summary

This study measured the ouabain-sensitive and ouabain-resistant adenosine triphosphatase activity in homogenates of the sciatic nerves and of pooled fourth and fifth lumbar dorsal root ganglia from rats fed 20% galactose or made diabetic with streptozotocin for either 4 or 8 weeks. Diabetes caused reductions in both fractions of sciatic nerve adenosine triphosphatase activity. After 8 weeks the ouabainsensitive fraction was 54% of control (p<0.05) and the ouabain-resistant fraction was 57% of control (p<0.05). Galactose feeding more than doubled the ouabain-sensitive adenosine triphosphatase activity in the sciatic nerve (225% of control after 4 weeks, 215% of control after 8 weeks of galactose feeding, bothp<0.01) and produced a progressive increase in the ouabain-resistant fraction (119% of control at 4 weeks (p<0.05) and 176% of control at 8 weeks (p<0.01)). In a group of rats fed galactose for 5 days, sciatic nerve ouabain-sensitive adenosine triphosphatase activity was 165% of control. Treatment with the aldose-reductase inhibitors tolrestat, ponalrestat or sorbinil prevented accumulation of polyol and depletion of myo-inositol in the sciatic nerves, indicating effective inhibition of aldose reductase. These drugs prevented completely the effect of galactose on the sciatic nerve adenosine triphosphatase activity, but had no significant effect on the reduction in adenosine triphosphatase activity in the sciatic nerves of diabetic rats. In the dorsal root ganglia galactose feeding had no measurable effect on the adenosine triphosphatase activity. Diabetes caused a modest numerical reduction in the ouabain-sensitive activity only. The findings indicate markedly different effects of diabetes and galactosaemia on the adenosine triphosphatase activity in rat sciatic nerve and show that the reduction in activity seen in the nerves of diabetic rats was not related to exaggerated polyol pathway flux.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Willars GB, Lambourne JE, Tomlinson DR (1988) Does galactose feeding provide a valid model of exaggerated polyol-path-way flux in peripheral nerve in experimental diabetes? Diabetes 36: 1425–1431

    Google Scholar 

  2. Lambourne JE, Tomlinson DR, Brown AM, Willars GB (1987) Opposite effects of diabetes and galactosaemia on ATPase activity in rat nervous tissue. Diabetologia 30: 360–362

    Article  CAS  PubMed  Google Scholar 

  3. Das PK, Bray GM, Aguayo AJ, Rasminsky M (1976) Diminished ouabain-sensitive, sodium-potassium ATPase activity in sciatic nerves of rats with streptozotocin-induced diabetes. Exp Neurol 53: 285–288

    Article  CAS  PubMed  Google Scholar 

  4. Greene DA, Lattimer S, Ulbrecht J, Carroll P (1985) Glucose-induced alterations in nerve metabolism: current perspective on the pathogenesis of diabetic neuropathy and future directions for research and therapy. Diabetes Care 8: 290–299

    CAS  PubMed  Google Scholar 

  5. Greene DA, Lattimer SA (1984) Action of sorbinil in diabetic peripheral nerve: relationship of polyol (sorbitol) pathway inhibition to a myo-inositol-mediated defect in sodium-potassium ATPase activity. Diabetes 33: 712–716

    CAS  PubMed  Google Scholar 

  6. Mayer JH, Tomlinson DR (1983) Prevention of defects of axonal transport and nerve conduction velocity by oral administration ofmyo-inositol or an aldose reductase inhibitor in streptozotocindiabetic rats. Diabetologia 25: 433–438

    Article  CAS  PubMed  Google Scholar 

  7. Willars GB, Calcutt NA, Tomlinson DR (1987) Impaired axonal transport of phosphofructokinase in streptozotocin-diabetic rats; effects of insulin and the aldose reductase inhibitor, ‘ponalrestat’. Diabetologia 30: 239–243

    Article  CAS  PubMed  Google Scholar 

  8. Greene DA, Yagihashi S, Lattimer SA, Sima AAF (1984) Nerve Na+-K+-ATPase, conduction, and myo-inositol in the insulin- deficient BB rat. Am J Physiol 247: E534–E539

    CAS  PubMed  Google Scholar 

  9. Greene DA, Chakrabarti S, Lattimer SA, Sima AAF (1987) Role of sorbitol accumulation and myo-inositol depletion in parano- dal swelling of large myelinated fibers in the insulin-deficient spontaneously diabetic Bio-breeding rat. J Clin Invest 79: 1479–1485

    CAS  PubMed  Google Scholar 

  10. Calcutt NA, Tomlinson DR, Willars GB (1988) Ganglioside treatment of diabetic rats; effects on nerve adenosine triphosphatase activity and motor nerve conduction velocity. Life Sci 42: 1515–1520

    Article  CAS  PubMed  Google Scholar 

  11. Greene DA, Lattimer SA (1983) Impaired rat sciatic nerve sodium-potassium ATPase in acute streptozotocin diabetes and its correction by dietary myo-inositol supplementation. J Clin Invest 72: 1058–1063

    CAS  PubMed  Google Scholar 

  12. Lambourne JE (1988) Neurological defects in galactose-fed rats. PhD Thesis, University of Nottingham, pp 69–70

  13. Llewelyn JG, Thomas PK (1987) Perineurial sodium-potassium- ATPase activity in streptozotocin-diabetic rats. Exp Neurol 97: 375–382

    Article  CAS  PubMed  Google Scholar 

  14. Llewelyn JG, Patel NJ, Thomas PK, Stribling D (1987) Sodium, potassium adenosine triphosphatase activity in peripheral nerve tissue of galactosaemic rats. Effect of aldose reductase inhibition. Diabetologia 30: 971–972

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lambourne, J.E., Brown, A.M., Calcutt, N. et al. Adenosine triphosphatase in nerves and ganglia of rats with streptozotocin-induced diabetes or galactosaemia; effects of aldose reductase inhibition. Diabetologia 31, 379–384 (1988). https://doi.org/10.1007/BF02341507

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02341507

Key words

Navigation